REDEGALLI, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 135
NA - Nord America 58
AS - Asia 41
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 237
Nazione #
IT - Italia 98
US - Stati Uniti d'America 58
CN - Cina 25
SG - Singapore 12
SE - Svezia 11
RU - Federazione Russa 7
FI - Finlandia 4
AT - Austria 2
BR - Brasile 2
CH - Svizzera 2
DE - Germania 2
FR - Francia 2
IE - Irlanda 2
PL - Polonia 2
TW - Taiwan 2
ES - Italia 1
EU - Europa 1
GB - Regno Unito 1
KR - Corea 1
MD - Moldavia 1
VN - Vietnam 1
Totale 237
Città #
Milan 36
Shanghai 14
Ashburn 12
Boardman 9
Singapore 8
Dallas 5
Lappeenranta 4
New York 4
Parma 4
Pisa 4
Trento 3
Brembate di Sopra 2
Chengdu 2
Cittadella 2
Dublin 2
Fiesole 2
Guanzate 2
Lawrence 2
Linz 2
Padova 2
Princeton 2
Rio de Janeiro 2
Rome 2
San Giovanni Lupatoto 2
Seattle 2
Warsaw 2
Brest 1
Cambridge 1
Ferrara 1
Geneva 1
Guangzhou 1
Legnano 1
London 1
Miami 1
Moscow 1
Plainfield 1
San Francisco 1
Segrate 1
Shenzhen 1
Turin 1
Washington 1
Zanica 1
Totale 149
Nome #
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 50
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 44
Locally Performed HRD Testing for Ovarian Cancer? Yes, We Can! 37
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 27
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 23
Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). 21
Fibronectin fragments generated by pancreatic trypsin act as endogenous inhibitors of pancreatic tumor growth 17
Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells 15
Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine Tumors 14
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples 11
ASO Visual Abstract: Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma 4
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 2
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 1
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 1
Totale 267
Categoria #
all - tutte 2.409
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 1 0 0 0 0 0 0
2021/20223 0 0 0 1 0 0 0 0 2 0 0 0
2022/202334 5 4 0 0 0 4 4 7 0 3 0 7
2023/2024130 4 4 17 14 10 8 8 18 3 11 13 20
2024/202599 28 15 27 21 8 0 0 0 0 0 0 0
Totale 267